BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2018

  Select Medical Holdings Corporation announced results for its fourth quarter and year ended December 31, 2018.

  February 21, 2019

   · 

  33 min read
• Job Trends

  Advocates Gather in Denver for First Suicide Prevention Day at the Capitol

  Suicide is the tenth leading cause of death in the United States and the seventh leading cause of death in Colorado.

  February 21, 2019

   · 

  3 min read
• Deals

  OBIO Opens 2019 Niagara Investment Summit, Connecting Canada’s Most Promising Innovations with Leading Global Investors

  OBIO is proud to announce the opening of the 2019 Niagara Investment Summit in Niagara-on-the-Lake, Ontario, on February 21-22, 2019.

  February 21, 2019

   · 

  2 min read
• Business

  Progenity Announces Expansion of Board of Directors

  Company Focused on Diagnostic and Therapeutic Precision Medicine Solutions in Prenatal and Perinatal Healthcare, Oncology, and Gastroenterology

  February 21, 2019

   · 

  7 min read
• Deals

  Boston Scientific Prices $4.3 Billion of Senior Notes

  Boston Scientific Corporation announced the pricing of a public offering of $4.3 billion aggregate principal amount of its senior notes under the Company’s shelf registration statement.

  February 21, 2019

   · 

  5 min read
• Policy

  Aradigm Announces Receipt of Final FDA Minutes for the Type B Meeting on January 25, 2019

  At the Type B meeting, Aradigm presented the results of the Third Party Evaluation (TPE) completed in December 2019 that addressed the clinical issue raised by the FDA in the complete response letter (CRL) received in January 2018.

  February 21, 2019

   · 

  5 min read
• Deals

  Ocular Therapeutix™ Prices $37.5 Million Subordinated Convertible Debt Financing

  Ocular Therapeutix™, Inc. announced that it has entered into a note purchase agreement with an accredited investor to issue $37.5 million aggregate principal amount of 6.00% subordinated convertible notes due 2026 pursuant to Regulation D promulgated under the Securities Act of 1933, as amended.

  February 21, 2019

   · 

  7 min read
• Business

  Alimentation Couche-Tard and Canopy Growth join forces to launch a premium cannabis retail brand in London, Ontario

  Alimentation Couche-Tard Inc. has entered into a multi-year agreement with Canopy Growth Corporation.

  February 21, 2019

   · 

  10 min read
• Biotech Beach

  HCP to Present at Citi’s 2019 Global Property CEO Conference

  HCP, Inc. announced that Tom Herzog, its President and CEO, is scheduled to present at Citi’s 2019 Global Property CEO Conference in Hollywood, Florida.

  February 21, 2019

   · 

  1 min read
• Business

  eHealth, Inc. Announces Fourth Quarter and Fiscal 2018 Results

  Revenue for the fourth quarter of 2018 was $134.9 million, an increase of 62% compared to $83.1 million for the fourth quarter of 2017.

  February 21, 2019

   · 

  56 min read